Dr. Bellamkonda Kishore Honored with Outstanding Editor Award in Renal and Epithelial Physiology

Dr. Bellamkonda Kishore has been honored with the Outstanding Editor Award in Renal and Epithelial Physiology Specialty Section by Frontiers in Physiology, a Switzerland-based publication last week.

In a message sent to Dr. Kishore, Publishing Development Journal Manager at Frontiers in Lausanne in Switzerland, Georgina Harris, PhD wrote: “As Frontiers in Physiology reaches 10,000 published articles and more than 10 years online, on behalf of our Chief Editors, we are honored to award you the Outstanding Editor Award in Renal and Epithelial Physiology Specialty Section for your strong editorial contribution to Frontiers in Physiology.”

Mr. Harris added: “We would like to highlight our outstanding editors and share our gratitude towards your editorial efforts via social media. Thank you for your strong support for the Journal and providing your time and expertise towards our mission to make all science open!”

Dr. Kishore has more 30 years of research experience in renal physiology,  pathophysiology and experimental therapeutics gained in India, Japan, Beligum and the United States, which includes the Intramural Research Program of the National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland. Currently he directs an internationally recognized research program at the VA Salt Lake City Health Care System and the University of Utah Health. His current research focuses on the role of purinergic signaling in the genesis of clinically relevant water balance disorders, diet-induced obesity and insulin resistance, and vasopressin excessive states, such as cirrhosis of liver, autosomal dominant polycystic kidney disease (ADPKD) and others.

Dr. Kishore and his collaborators identified and filed patents for novel drug targets for the treatment of acquired NDI and diet-induced obesity, and vasopressin excessive states. In addition, Dr. Kishore and his collaborators developed and patented a novel method to induce proliferation of erythropoietin (EPO)-producing cells in the kidney. Over the years, Dr. Kishore’s research has been funded by the Department of Veterans Affairs, National Institute of Diabetes and Digestive and Kidney Diseases, National Foundation of Utah & Idaho, University of Utah Research Foundation, Western Institute for Biomedical Research and Eye Foundation of America. Dr. Kishore was recently appointed the Chief Editor of JAAPI, the Journal of American Association of Physicians of Indian Origin.

The poetical Tribute, A Pandemic Gitanjali by Dr. Kishore on The Pandemic: Covid -19 displays this unique skills as a writer and thoughtful leader in the Healthcare Industry.


Leave a Reply

Your email address will not be published. Required fields are marked *

More Related Stories